Business Standard

Pharma SMEs stock up on a month's raw material amid supply disruptions

The lockdown in various Chinese provinces, including Shanghai, is likely to delay shipments by two weeks to a month, said domestic players.

pharmacy, drugs, medicine, pharma companies, pharmaceuticals
Premium

Even smaller drug makers are now carrying a month of buffer stock of key raw materials, said industry insiders.

Sohini Das Mumbai
With intermittent disruptions in the supply chain of raw materials from China, the Indian pharma industry has braced itself with bigger inventory. Even smaller drug makers are now carrying a month of buffer stock of key raw materials, said industry insiders.

The lockdown in various Chinese provinces, including Shanghai, is likely to delay shipments by two weeks to a month, said domestic players. Shipments are critical for the Indian drug industry, which imports 70 per cent of its raw material from China. Some products, such as antibiotics and vitamins (fermentation bulk drugs), are imported to the extent of 90 per cent

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 31 2022 | 12:36 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com